Toria / Shutterstock.com
On December 7, LSIPR will be hosting the Life Sciences Patents Network Europe 2016 at the Bloomsbury Hotel in London. Here we preview the main talking points.
Newton Media, the publisher of Life Sciences IP Review, is excited to host this publication’s first event. On December 7, 2016, the best and brightest people working in life sciences intellectual property, including in-house counsel and private practitioners, will converge on the Bloomsbury Hotel in London for a day of networking, education and debate.
So far, we have confirmed speakers from leading drugs companies Bayer, GSK, Novartis and Lundbeck, among others, and representatives from the European Patent Office and the European Commission will also be presenting.
We have attempted to cover as many important topics as possible in one day, but a couple stand out.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bayer, GSK, Novartis, Life Sciences Patents Network Europe 2016, supplementary protection certificates, generic, patent, life sciences,